Company Filing History:
Years Active: 2007-2008
Title: The Innovative Contributions of Robert E. Yule
Introduction
Robert E. Yule is a notable inventor based in Green Oaks, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target corticotropin releasing factor (CRF) receptor antagonists. With a total of 2 patents, Yule's work has implications for treating anxiety and depression.
Latest Patents
Yule's latest patents include a process for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof. This invention provides novel processes and intermediates for preparing CRF receptor antagonists, which are useful in treating CRF-related disorders such as anxiety and depression. The innovative methods outlined in his patents are expected to advance therapeutic options in mental health.
Career Highlights
Robert E. Yule is currently associated with Bristol-Myers Squibb Pharma Company, where he continues to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in the preparation of complex chemical compounds has positioned him as a valuable asset in his field.
Collaborations
Yule has collaborated with notable colleagues, including James P. Sherbine and Shawn K. Pack. These partnerships have fostered an environment of innovation and have led to the successful development of new pharmaceutical solutions.
Conclusion
Robert E. Yule's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments for mental health disorders.